Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BRZENASDAQ:DOCSNYSE:IONQNASDAQ:NICE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBRZEBraze$26.76+0.1%$31.81$25.22▼$48.33$2.83B1.221.30 million shs3.31 million shsDOCSDoximity$61.19+1.3%$56.21$25.00▼$85.21$11.49B1.332.17 million shs4.82 million shsIONQIonQ$40.23-2.2%$36.08$6.22▼$54.74$10.53B2.5919.30 million shs21.58 million shsNICENice$165.09-0.4%$163.69$137.19▼$200.65$10.44B1.01517,331 shs285,343 shsOptions Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBRZEBraze0.00%+3.56%-26.56%-28.66%-25.46%DOCSDoximity0.00%+6.47%+17.80%+4.78%+121.15%IONQIonQ0.00%-0.07%-6.48%+75.53%+497.82%NICENice0.00%+1.53%-1.43%+6.18%+1.55%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBRZEBraze3.6578 of 5 stars4.52.00.00.02.43.30.6DOCSDoximity2.2425 of 5 stars2.30.00.00.01.94.21.3IONQIonQ0.7642 of 5 stars1.33.00.00.02.61.70.0NICENice4.0314 of 5 stars4.32.00.00.02.61.72.5Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBRZEBraze 2.95Moderate Buy$46.3073.02% UpsideDOCSDoximity 2.59Moderate Buy$63.113.13% UpsideIONQIonQ 2.67Moderate Buy$40.00-0.58% DownsideNICENice 2.69Moderate Buy$209.7527.05% UpsideCurrent Analyst Ratings BreakdownLatest BRZE, DOCS, IONQ, and NICE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/25/2025DOCSDoximityBank of AmericaSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$55.00 ➝ $62.006/25/2025IONQIonQBenchmarkSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$50.006/24/2025BRZEBrazeOppenheimerSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$44.00 ➝ $38.006/20/2025NICENiceDA DavidsonSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$185.00 ➝ $195.006/20/2025NICENiceWedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$200.006/18/2025NICENiceRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$200.006/18/2025NICENiceCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$161.006/18/2025NICENiceJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$300.006/18/2025NICENiceRosenblatt SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$190.006/13/2025NICENicePiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutral ➝ Neutral$153.00 ➝ $182.006/11/2025IONQIonQNeedham & Company LLCSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$50.00(Data available from 6/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBRZEBraze$593.41M4.76N/AN/A$4.49 per share5.96DOCSDoximity$570.40M20.15$0.75 per share81.32$5.52 per share11.09IONQIonQ$43.07M244.40N/AN/A$1.77 per share22.73NICENice$2.74B3.82$11.85 per share13.93$56.97 per share2.90Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBRZEBraze-$103.74M-$1.01N/AN/AN/A-16.76%-18.89%-10.26%9/4/2025 (Estimated)DOCSDoximity$147.58M$1.1161.1957.194.1036.60%21.75%18.64%N/AIONQIonQ-$331.65M-$1.49N/AN/AN/A-753.20%-63.35%-54.65%8/6/2025 (Estimated)NICENice$442.59M$7.1723.0315.191.5016.77%16.37%11.15%8/13/2025 (Estimated)Latest BRZE, DOCS, IONQ, and NICE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/5/2025Q1 2026BRZEBraze$0.05$0.07+$0.02-$0.34$158.60 million$162.06 million5/15/2025N/ADOCSDoximity$0.27$0.38+$0.11N/AN/AN/A5/15/2025Q1 2025NICENice$2.84$2.87+$0.03$2.01$699.46 million$700.19 million5/7/2025Q1 2025IONQIonQ-$0.28-$0.14+$0.14-$0.14$7.51 million$7.57 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBRZEBrazeN/AN/AN/AN/AN/ADOCSDoximityN/AN/AN/AN/AN/AIONQIonQN/AN/AN/AN/AN/ANICENiceN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBRZEBrazeN/A1.921.92DOCSDoximityN/A8.748.74IONQIonQN/A13.1713.17NICENiceN/A1.601.60Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBRZEBraze90.47%DOCSDoximity87.19%IONQIonQ41.42%NICENice63.34%Insider OwnershipCompanyInsider OwnershipBRZEBraze18.20%DOCSDoximity37.40%IONQIonQ5.20%NICENice0.02%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBRZEBraze1,699105.61 million86.39 millionOptionableDOCSDoximity890187.83 million116.87 millionNot OptionableIONQIonQ100261.63 million248.03 millionOptionableNICENice8,72663.25 million63.24 millionOptionableBRZE, DOCS, IONQ, and NICE HeadlinesRecent News About These CompaniesDavid Corenswet Opened Up About Meeting Christopher Reeve's Son On The Superman Set: 'It Was Nice In A Lot Of Different Ways'June 28 at 8:32 PM | msn.com‘Nice boy’ Enzo Fernandez ‘will be even better next season’ – MarescaJune 28 at 10:42 AM | sports.yahoo.com‘Squid Game’ finale lays bare a reality: The wealthy win and nice guys finish lastJune 28 at 10:42 AM | msn.comStaying nice this weekend with more showers next weekJune 28 at 5:41 AM | kktv.comKHarriette Cole: Why can’t we have a nice anniversary like my friends did?June 28 at 5:41 AM | mercurynews.comMAsset Management One Co. Ltd. Has $7.39 Million Stock Holdings in Nice (NASDAQ:NICE)June 28 at 3:40 AM | marketbeat.comTrump Turns on ‘Nice’ Carney With Canadian Tech Tax UltimatumJune 27 at 9:06 PM | financialpost.comFNice (NASDAQ:NICE) Shares Acquired by Perpetual LtdJune 27 at 5:48 AM | marketbeat.comOppenheimer & Co. Inc. Lowers Holdings in Nice (NASDAQ:NICE)June 27 at 4:04 AM | marketbeat.comFrench court orders Nice mayor to remove Israeli flags from city hallJune 26 at 6:12 PM | dailysabah.comDOGC Nice’s Sofiane Diop undergoes sports hernia surgeryJune 26 at 6:12 PM | getfootballnewsfrance.comGGet Nice Holdings Limited Declares Final Dividend for FY 2025June 26 at 10:11 AM | tipranks.comGet Nice Holdings Limited Reports Resilient Financial Performance for 2025June 26 at 10:11 AM | tipranks.comOfficial | OGC Nice sign Manchester City centre-back Juma Bah on loanJune 26 at 7:58 AM | sports.yahoo.comA CT man with the street name ‘Nice’ went to another state to deal drugs. Guns were involved.June 26 at 7:58 AM | courant.comCCyclists complete charity ride from Leeds to NiceJune 26 at 7:58 AM | msn.comGossip: Sunderland monitor Nice goalkeeperJune 26 at 7:58 AM | msn.comBalefire LLC Purchases 7,540 Shares of Nice (NASDAQ:NICE)June 26 at 7:20 AM | marketbeat.comNice (NASDAQ:NICE) Shares Sold by Bessemer Group Inc.June 26 at 5:30 AM | marketbeat.comDA Davidson Estimates Nice's Q2 Earnings (NASDAQ:NICE)June 26 at 2:21 AM | americanbankingnews.comNiCE-Snowflake partnership addresses a significant AI customer pain pointJune 25, 2025 | siliconangle.comSNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack ModeIonQ’s $1B Acquisition and Drug Discovery Leap With NVIDIABy Leo Miller | June 12, 2025View IonQ’s $1B Acquisition and Drug Discovery Leap With NVIDIABRZE, DOCS, IONQ, and NICE Company DescriptionsBraze NASDAQ:BRZE$26.76 +0.02 (+0.07%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$26.76 -0.01 (-0.02%) As of 06/27/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Braze, Inc. operates a customer engagement platform that provides interactions between consumers and brands worldwide. The company offers Braze software development kits that automatically manage data ingestion and deliver mobile and web notifications, in-application/in-browser interstitial messages, and content cards; REST API that can be used to import or export data or to trigger workflows between Braze and brands' existing technology stacks; Partner Data Integrations, which allow brands to sync user cohorts from partners; Data Transformation, in which brands can programmatically sync and transform user data; and Braze Cloud Data Ingestion that enables brands to harness their customer data. It also offers classification products, including segmentation that can define reusable segments of consumers based upon attributes, events, or predictive propensity scores; segment insights, which allows customers to analyze how segments are performing relative to each other across a set of pre-selected key performance indicators; and predictive suite that allows customers to identify groups of consumers that are of critical business value. In addition, the company provides Canvas, an orchestration tool that allows customers to create journeys, mapping out multi-steps, and cross-channel messaging experiences; campaigns, which allows customers to send one set of single-channel or multi-channel messages to be delivered to customers in a particular user segment; event and API triggering; marketing pressure management; and reporting and analytics. Further, it offers personalization products, such as liquid templating platform, connected content platform, content blocks, intelligent timing and channel, personalized variant, and AI item recommendations, and catalogs; and action products. The company was formerly known as Appboy, Inc. and changed its name to Braze, Inc. in November 2017. Braze, Inc. was incorporated in 2011 and is headquartered in New York, New York.Doximity NASDAQ:DOCS$61.19 +0.78 (+1.29%) Closing price 06/27/2025 03:59 PM EasternExtended Trading$61.08 -0.11 (-0.18%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.IonQ NYSE:IONQ$40.23 -0.89 (-2.16%) Closing price 06/27/2025 03:59 PM EasternExtended Trading$40.22 -0.01 (-0.02%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IonQ, Inc. engages in the development of general-purpose quantum computing systems in the United States. It sells access to quantum computers of various qubit capacities. The company makes access to its quantum computers through cloud platforms, such as Amazon Web Services (AWS) Amazon Braket, Microsoft's Azure Quantum, and Google's Cloud Marketplace, as well as through its cloud service. It also provides contracts associated with the design, development, and construction of specialized quantum computing hardware systems; maintenance and support services; and consulting services related to co-developing algorithms on quantum computing systems. The company was founded in 2015 and is headquartered in College Park, Maryland.Nice NASDAQ:NICE$165.09 -0.59 (-0.36%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$164.25 -0.84 (-0.51%) As of 06/27/2025 06:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NICE Ltd., together with its subsidiaries, provides cloud platforms for AI-driven digital business solutions worldwide. It offers CXone, a cloud native open platform; Enlighten, an AI engine for the customer engagement market; and smart self service enable organizations to address consumers' needs; and journey orchestration solutions that empower organizations to connect and route customers to deal with the customer's request, and connects them using real time AI-based routing. The company provides smart self service solutions that empower organizations to build intelligent automated conversations based on data; and prepared agent solutions and tools enable contact center agents to guide and alert them in real time; provides solutions that help organizations to record structured and unstructured customer interaction and transaction data; and NICE Evidencentral, an digital evidence management platform for public safety emergency communications, law enforcement, and criminal justice helps agencies. In addition, it offers X-Sight, is an open and flexible AI-cloud platform for financial crime and compliance; Xceed, a cloud platform for comprehensive AML and fraud prevention for small and mid-sized organizations; data intelligence solutions that enable organizations to turn raw data into comprehensive actionable intelligence to prevent and detect financial crimes; AI and analytics technologies to detect and prevent financial crimes in real-time; money laundering and fraud prevention solutions that help organizations adhere to capital markets compliance and anti-money laundering compliance regulations; intelligent investigations solutions; and self-service solutions that provide organizations with customization and self-development capabilities. The company was formerly known as NICE-Systems Ltd. and changed its name to NICE Ltd. in June 2016. NICE Ltd. was founded in 1986 and is headquartered in Ra'anana, Israel. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Addition by Subtraction: Intel’s New Strategy Energizes Investors Apple: The Mag 7’s Dead Money Stock or AI Cash Cow in the Making? NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Broadcom’s Big VMware Update: A Threat to Public Cloud Giants? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
